breast cancer Archives
Breast cancer program lands new research grants
Mar. 23, 2017—Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients.
Softening tumor tissue could aid cancer treatments
Jan. 16, 2017—Tumors cause the intracellular material surrounding them to stiffen. Softening this protective layer could make existing cancer treatments more effective, according to new research.
Targeting the “un-targetable”
Nov. 18, 2016—A novel drug that targets the protein RSK blocked aggressive breast cancers from metastasizing in an animal model.
BMI genotype and breast cancer risk
Sep. 29, 2016—For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults.
National Lymphedema Network honors VUMC research efforts
Sep. 22, 2016—Lymphedema research conducted at Vanderbilt University Medical Center (VUMC) to better understand patient risk for this chronic condition and treatment responses received recognition at an international conference.
In search of new cancer targets
Sep. 9, 2016—Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.
New breast cancer driver
Aug. 26, 2016—Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.
Breast cancer: finding the smoking gun
Jul. 20, 2016—A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes.
VICC researchers to study reasons for high breast cancer incidence and mortality rates among African-American women
Jul. 6, 2016—A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.
Study explores how some breast cancers resist treatment
Apr. 21, 2016—A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.
Switching breast cancer off
Apr. 14, 2016—Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.
Annual Pink Out women’s basketball game set for Feb. 14
Feb. 11, 2016—Pink will be the dominant color in Memorial Gymnasium Sunday, Feb. 14, as the Vanderbilt Commodores Women’s Basketball team participates in the annual Pink Out! game to raise awareness about breast cancer.
